StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Rating) in a report issued on Sunday morning. The firm issued a buy rating on the stock. Separately, TheStreet downgraded Trinity Biotech from a c- rating to a d- rating in a research note on Monday, December 20th. TRIB stock opened at $1.02 on […]